Literature DB >> 6309725

Synthesis and biological properties of sodium (5R, 6S, 8R)-6 alpha-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.

G Franceschi, M Foglio, M Alpegiani, C Battistini, A Bedeschi, E Perrone, F Zarini, F Arcamone, C Della Bruna, A Sanfilippo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6309725     DOI： 10.7164/antibiotics.36.938

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of the penem CP-65,207 and its separate stereoisomers in humans.

Authors:  G Foulds; A K Knirsch; J D Lazar; T G Tensfelt; N Gerber
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Interaction of FCE 22101 with penicillin-binding proteins of Staphylococcus aureus.

Authors:  E A Tonin; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101.

Authors:  A L Barry; K E Aldridge; S D Allen; P C Fuchs; E H Gerlach; R N Jones; M A Pfaller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

4.  Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease.

Authors:  W G Boersma; S M Puister; R van Altena; H G de Vries-Hospers; M Molinari; G H Koëter
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

5.  The effect of FCE 22891, a new oral penem, on faecal flora anaerobes and their fermentation end products in patients with chronic obstructive pulmonary disease.

Authors:  G J Meijer-Severs; E van Santen; S M Puister; W G Boersma
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

6.  Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose.

Authors:  M G Jannuzzo; M Mandelli; M S Benedetti; E Moro; M Carnovali; R Vaiani; D Sassella
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.